Detalhe da pesquisa
1.
Risk factors for and outcomes of ring expulsions with a 1-year contraceptive vaginal system.
Am J Obstet Gynecol
; 230(5): 548.e1-548.e8, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38295968
2.
Assessing the acceptability of, adherence to and preference for a dual prevention pill (DPP) for HIV and pregnancy prevention compared to oral pre-exposure prophylaxis (PrEP) and oral contraception taken separately: protocols for two randomised, controlled, cross-over studies in South Africa and Zimbabwe.
BMJ Open
; 14(3): e075381, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38479746
3.
Results of a phase 1, randomized, placebo-controlled first-in-human trial of griffithsin formulated in a carrageenan vaginal gel.
PLoS One
; 17(1): e0261775, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35051209
4.
Bleeding profile associated with 1-year use of the segesterone acetate/ethinyl estradiol contraceptive vaginal system: pooled analysis from Phase 3 trials.
Contraception
; 100(6): 438-444, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31398307